🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

3 notícias encontradas para "suffering"
Foto: Kritsada Seekham / Pexels
Dicas
Andy Burnham must act fast on the climate – or risk getting stuck in a ‘derailment’ doom loop | Laurie Laybourn
Around the world, climate-sceptic parties are exploiting floods and fires to make political capital. Without urgent changes, this deadly spiral will continueRecent unprecedented heatwaves in the UK may have killed thousands of people. Children are suffering in overheating schools. NHS trusts are straining under record-breaking demand. This all comes after climate extremes have even affected national security, with three of Britain’s five worst harvests coming since 2020, impairing food
Foto: Rino Adamo / Pexels
Dicas
Here’s how Andy Burnham can finance a reindustrialised Britain – without doing a Liz Truss | Larry Elliott
Britain’s PM-in-waiting is right that the country has been failed by 40 years of neoliberalism. There will be obstacles, but he must embrace radicalism Of all the many prime ministers who have walked through the doors of 10 Downing Street in the past decade, the one Andy Burnham resembles most is Liz Truss. Both had a view of what was going wrong with the economy. Both wanted to break with the politics of managed decline. Both had ambitious ideas for what needed to be done.Truss, of co
Foto: Mitchell Henderson / Pexels
Dicas
UK housing market downturn eases but sentiment remains ‘fragile’, surveyors say – business live
Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand